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Confirmation of the utility of fine needle aspiration biopsy of the renal
allograft. Allograft immunobiologic theory would predict that analysis
of immunocompetent cells infiltrating the renal transplant would be
most instructive. Recently a new aspiration biopsy technique has been
developed to permit such analysis in patients which can be safely and
repetitively performed. The clinical utility of such a technique has been
tested utilizing a randomized prospective trial in which an aspirate was
obtained every other day from the third post-operative day until
discharge. Analysis included examination of adequacy criteria and the
capacity of pathologic diagnosis to corroborate clinical diagnosis from
coded specimens. Ninety-six aspirates from 21 consenting transplant
recipients were obtained and analyzed. In 94 instances a clinical
diagnosis could be made; 80 aspirates fulfilled adequacy criteria. We
found the technique to be highly sensitive ( 90%) and highly specific
( 90%) for the clinical diagnoses of acute allograft rejection, post-
operative acute renal failure, cyclosporine toxicity, and normal func-
tion. We conclude that the fine needle aspiration technique is an
important adjunct to analysis of clinical renal transplantation and offers
a major advantage to the clinical scholar in understanding transplant
biology.
Careful dissection of immune cell trafficking patterns has led
to the view that determination of the inflammatory events
occurring within a renal transplant permits accurate assessment
of the response of the transplant recipient to alloantigen. This
notion has engendered interest in the development of a safe and
easy method for repetitively examining the inflammatory cell
infiltrate in an allograft after implantation. The importance of
understanding the intragraft events for explication of immune
mechanisms that govern transplantation biology and for assess-
ment of clinical function was highlighted by Strom and co-
workers examining cells recovered from irrevocably rejected
allografts [1]. Later, building on the development of the aspira-
tion biopsy technique first described for the renal transplant by
Pasternack [2], the research team of Hayry and von Willebrand
has developed the technique of fine needle aspiration biopsy of
the renal transplant to the point at which the clinical utility of
the technique can be carefully assessed [3—6]. During the
several years of development of the fine needle aspiration
technique, the morphologic parameters of the intragraft inflam-
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matory events have been carefully delineated in several animal
models of allograft rejection, applied broadly to human clinical
diagnoses, and used to expand an understanding of the science
of anti-allograft immune response. Although the fine needle
aspiration biopsy technique has developed a small following in
Europe, many in Europe and the United States remain skepti-
cal. In order to assess the clinical utility of the fine needle
aspiration biopsy technique in human renal transplantation, we
undertook a randomized, prospective and controlled study
which sought to correlate the capacity of the reader of the
aspirate to approximate the clinical diagnosis rendered indepen-
dently by clinicians caring for the patient, the latter diagnosis
confirmed by data utilizing other modalities of investigation.
Methods
Patients
Potential subjects for the study were all renal allograft
recipients at the University of Texas Health Science Center at
Dallas—Parkland Memorial Hospital Transplant Program who
received kidneys from February through June of 1986. These
patients all received the same treatment algorithm. Sequential
induction therapy was employed perioperatively in which pa-
tients received Minnesota ALG (14 mg/kg), prednisione (100
mg), and azathioprine (25 mg) for the first four postoperative
days followed by the addition of cyclosporine A (7 mg/kg) on
day 5. If the allograft functioned, cyclosporine was raised to 12
mg/kd/day on day 6, prednisilone was tapered to 20 mg/d by day
21, and ALG and azathioprine were discontinued. In the face of
ATN, the ALO-prednisilone-azathioprine regimen is given for a
maximum of 14 days after which cyclosporine A and prednisi-
lone were begun regardless of function. All first rejection
episodes were treated with bolus steroids (1 g x 4) but without
reduction in cyclosporine. Consenting individuals were aspi-
rated as close to the third post-operative day as possible and
thence on an every-other-day schedule until discharged from
the hospital. For those recipients who were later readmitted for
transplantation problems and who were initially entered in the
study, fine needle aspirates were performed on readmission,
again on an every-other-day basis until discharged. All aspirates
received a five digit coded number developed by a randomized
number program and submitted to the pathologist for analysis
without further information. In a separate data book the attend-
376
Helderman et at: Fine needle aspiration of the transplant 377
ing physician on the transplant unit rendered a clinical diagnosis
based on history, physical, laboratory information, and special
studies (core renal biopsy, renal scan, renal sonogram, cyclo-
sporine blood levels, isotopic clearance determinations of gb-
merular filtration rate and/or urologic studies). The clinical
impression was confirmed by response to a given therapeutic
approach and/or the special studies as listed. In almost half of
the diagnoses of rejection that diagnosis was confirmed by core
biopsy in addition to response to a therapeutic maneuver.
Moreover, renal functional response to anti-rejection treatment
was considered corroborative of the diagnosis of rejection since
the cyclosporine dose was not reduced in that setting ruling out
a misdiagnosis of cyclosporine toxicity. At the completion of
the data collection, the code was broken and the degree of
agreement between the clinical assessment of the patient and
the fine needle aspiration biopsy reading was made.
Aspiration technique
The fine needle aspiration biopsy was performed entirely by
the method described by Hllyry and von Willebrand [3—5]. In
brief, after sterile preparation, the patient is placed in a supine
position rotated to the contralateral hip with the contralateral
leg bent and the ipsilateral leg held taut. The allograft is entered
with a 25 gauge pediatric spinal needle (Becton Dickinson,
Mountainview, California, USA). The trocar is removed and
the spinal needle is attached to a 10 ml plastic syringe fitted into
an aspiration gun (Comeco, Inc., Sweden) that had been
previously filled with 4 to 5 ml of tissue culture media (500 ml
RPMI 1640; 5 ml glutamine; 2.5 ml heparin, 5000 2.5 ml 20%
human albumin; 0.5 ml 1 M hepes, 23.8 g 100 ml H20; filtered
through 0.2 IL filter). When suction is applied to the spinal
needle a 10 to 20 IL1 size specimen is removed from the
transplant filling the hub of the spinal needle. This material must
be washed into the tissue culture media in the syringe by
ejecting the sample into a sterile 3 cc tissue culture test tube and
washing the specimen through the hub of the needle several
times. The aspirate is performed without local anesthesia and
may be done without assessment of the clotting capacity of the
patient, intravenous fluid administration, or preparation of
blood for a transfusion. Simultaneously, a peripheral blood
specimen of a similar size is obtained from a finger stick into a
3 cc syringe filled with approximately 1.5 ml of the same tissue
culture media. The specimens were generally processed imme-
diately but may remain in the refrigerator without harm over
night. Glass microscope slides of the cellular aspirated material
were prepared by cytocentrifugation followed by May-Grfln-
wald-Giemsa conventional staining. Additional assessment of
the nature of the cells in most of the aspirates was accomplished
using monoclonal antibodies against surface markers followed
by immunoperoxidase staining of the cytocentrifuge prepared
slide [7].
Analysis of the cellular component
The May-GrUnwald-Giemsa stained material was used to
assess the nature of the cellular infiltrate, the presence of and
integrity of the parenchymal component of the renal allograft
and the potential for contamination by peripheral blood. The
precise nature of each cell type infiltrating the allograft was
determined by use of the morphologic parameters as set forth
by von Willebrand, Soots and Hhyry [3]. The diagnostic pre-
sumption used in this study requires the supposition that the
inflammatory cells which concentrate in the albograft itself are
qualitatively different than the nature of the cells found in
peripheral blood. The presence of antigen specific and antigen
non-specific immunocomponent cells which had homed to the
site of graft inflammation should be discerned to be out of
proportion to an enumeration of their distribution in peripheral
blood when immune activation in the graft is present. It is
necessary, therefore, to separate the allograft related inflamma-
tory process from the contamination of peripheral blood in the
aspirate. To screen for the presence of peripheral blood con-
tamination of the aspirated specimen and to determine whether
the graft had "enriched" for alloactivated immunocompetent
cells, an incremental scoring method was applied as described
by Hayry et al [4]. In brief, 100 inflammatory mononuclear cells
were counted on aspirates and on peripheral blood glass slides
simultaneously obtained. The numerical difference between the
two specimens for each cell type graft minus peripheral blood
was taken as evidence for a concentration of that given cell type
found alone in the allograft. Based on the careful animal work of
the Finland group, the relative capacity of a given cell type to be
predictive of immune activation has been empirically deter-
mined. The numerical differences for each cell type were
multiplied by the relative risk factor and the partial scores
added together to give a single integer score [3—6]. In prelimi-
nary studies [8] our group determined that an incremental score
of seven or more always indicated rejection, while a score of
three or less rarely indicated such a diagnosis. There was very
little overlap between these scores in our earlier study. An
additional line of evidence was utilized to render the diagnosis
of rejection—a total blast cell count per specimen. A specimen
with greater than six immunoblasts present per slide was taken
as evidence for albograft rejection regardless of the incremental
score (Fig. 1).
Tubular morphology was assessed in a semi-quantitative
fashion with changes ranging from 0 to +4 using the presence of
swelling, vacuolization, nuclear integrity, and pyknosis as
evidence for disrupted tubular cells. The presence of small
isometric cytoplasmic renal parenchymal vacuoles which filled
the cytoplasm of the cell was taken as evidence for cycbosporine
nephrotoxicity (Fig. 2) [9].
Adequacy criteria
Two potential technical errors may lead to misreading: 1)
contamination of the transplant aspirate with peripheral blood
and; 2) aspirate from a source other than the renal transplant
itself. As discussed above, the incremental scoring method was
employed to detect and eliminate specimens with substantial
blood contamination. Further, the criterion of Häyry and von
Willebrand requiring at least seven renal parenchymal cells per
100 inflammatory cells was used. This criterion has been
validated by demonstrating the high degree of reproducibility in
simultaneous, double aspirates of human renal allografts [10].
When both aspirates fulfilled this criterion the coefficient of
correlation between the incremental scores from each aspirate
was greater than 0.945 [101.
Results
Ninety-six aspirates from 21 consenting transplant recipients
were obtained and sent to pathology, coded for reading (Fig. 3).
378 Helderman et a!: Fine needle aspiration of the transplant
Fig. 1. Representative aspirate from a patient felt experiencing a clinical rejection with concordant pathologic morphology. A. Lymphoblast, the
hallmark of rejection, Note the nucleolus. B. Lymphocytes in various stages of maturity.
Fig. 2. Representative aspirate from a patient
felt clinically to exhibit cyclosporine
nephrotoxicity confirmed by the presence of a
high whole blood drug level and a fall in
serum creatinine upon adjustment of dose.
Note the uniform, isometric vacuoles present
in the cytoplasm of renal tubular cells.
There was a mean of 4 1 SEM aspirates per patient (range 2 to
13). In 94 instances, the clinical attending staff were able to
render one of four diagnoses based on bedside observation and
evaluation of laboratory and radiographic studies as described
in materials and methods: 1) acute rejection; 2) post-surgical
acute renal failure (also called ATN); 3) cyclosporine toxicity;
and 4) normal function. In two instances, aspirates were ob-
tained from patients at a time when the clinical attending staff
were unable to make a specific diagnosis nor were the labora-
tory studies instructive. Both of these cases were deleted from
our analysis. Of the remaining 94 instances in which a clinical
diagnosis was possible, 80 aspirates were felt to have enough
aspirate material to make a pathologic diagnosis which fulfilled
the adequacy criteria as established. The fourteen aspirates
deemed "inadequate" had either scanty cellular material and/or
a tubular cell count below the diagnostic criteria established.
The 85% success rate was comparable to the figure reported for
our pilot study [8}. In 75 of the 80 aspirates in which a
Fig. 3. The technical success in clinical
diagnosis and performance of "adequate"
aspirates.
Fig. 4. The concordance between the clinical
and pathologic diagnoses.
pathologic diagnosis could be made, the pathologic diagnosis
rendered was compatible with or completely agreed with the
clinical diagnosis made by the clinical staff (Fig. 4). In five of the
80 cases, the pathologic diagnosis was not similar to that made
by the clinical staff.
In 17 instances, aspirates were obtained when patients were
felt to be clinically undergoing an acute rejection. The rate of
rejection, 19%, is similar to our general experience in the
cyclosporine era and reflects a marked reduction from our
previous experience. In 15 of the cases, the pathologic diagno-
sis of the biopsy was completely diagnostic and agreed with the
clinical impression. In two instances, aspirations were obtained
from two separate patients in which the corrected incremental
score was below the diagnostic threshold to make the diagnosis
of rejection, and therefore was felt to be indicative of normal
transplant function. In both of these cases, the score of the
subsequent biopsy climbed to the diagnostic threshold allowing
a diagnosis of rejection to be made.
Of the 30 aspirates obtained when post-surgical acute renal
failure was clinically apparent, the fine needle aspiration was
either compatible with or diagnostic of ATN in 29. In a single
patient in which the fine needle aspiration biopsy led to a
diagnosis other than that compatible with ATN, the pathologist
felt rejection was present. In the setting of ATN, it is often
difficult to diagnose rejection. It is possible that rejection,
indeed, was also present in this case, but we have elected to
score this case as a false negative for the purposes of this study.
It is interesting to note that during the perioperative observation
period a greater fraction of patients with ATN did not experi-
ence a simultaneous rejection episode.
In 27 aspirates obtained from patients whose kidney function
was normal at the time of aspirate, 25 of these cases had normal
morphology on the fine needle aspirate. In two of the 27 cases,
altered tubular morphology compatible with a potential diagno-
sis of ATN was felt to be present. In that instance, the potential
mis-diagnosis by the fine needle aspiration biopsy is tempered
by the knowledge that excellent renal transplant function may
be present at a time when resolving post-surgical tubular
damage may also be present morphologically. Again we have
elected to score this a false positive for the purposes of data
analysis.
In each of three instances in which elevated serum creatinine
was commensurate with an elevated cyclosporine blood level
within the potentially toxic range (greater than 200 ng/ml, whole
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blood, high performance liquid chromatography), the patholo-
gist was able to suggest from the coded specimen the appropri-
ate diagnosis solely based on the finding of isometric cytosolic
vacuoles in the tubular cells.
Aspirates from patients with normal, stable function or
patients with post-surgical acute renal failure had scant mono-
clonal antibody staining for DR antigens on tubular cell com-
ponents. In contrast, during acute rejection, tubular cells be-
came markedly positive for the presence of Class 2 HLA
antigens.
Discussion
Potential complications of the fine needle aspiration tech-
nique were sought during the performance of this study to
confirm the utility of the aspiration technique in clinical prac-
tice. Absolutely no clinical problems were encountered during
the aspiration procedure. Neither microscopic nor macroscopic
hematuna occurred. Post-biopsy pain was not experienced by
the patients. The hematocrit, vital signs, renal function were
unaffected by the aspiration technique. Occasionally, it was
clear at the bedside that attempted aspiration had failed to
obtain an adequate specimen. At that time, a repeat aspiration
was performed immediately without difficulty and again with no
complication. Although every aspirate will not be readable, a
substantial fraction of such aspirates are, indeed, helpful to the
clinician. The elapsed time for the entire process, from obtain-
ing the aspirate at the bedside to preparing and staining the
slides, to the reading of the slides, can be as little as four hours.
The safety of the process allows for an aspirate in a difficult
diagnostic situation to be performed later on the same day if a
first aspirate was non-diagnostic or failed to meet the adequacy
criteria as established, without expectation of a complication
and with high degree of expectation for success.
There was an extraordinary agreement between the clinical
diagnosis made at the bedside and confirmed by standard
diagnostic studies and the reading of the pathologist of the slide
presented in a coded fashion. There were high degrees of
specificity and sensitivity of the technique for each of the
clinical diagnoses screened with no individual diagnosis less
than 90% for each those two variables. Clearly, the easiest
diagnosis to make by the fine needle aspiration technique is
acute cellular rejection (15 of 17 cases). The presence of a
multiplicity of isometric, cytosolic vacuoles in renal tubular
cells may be strong evidence for the presence of cyclosporine A
excess. Unfortunately, the small number of cases so encoun-
tered in our study population does not allow us to more
vigorously support this view. It remains to be seen further
whether such vacuoles are indicative of high blood levels alone
or of clinical toxicity. Additional studies in human transplanta-
tion and in carefully managed animal models will be required to
further analyze this point. There has been some debate as to
whether these vacuoles contain cyclosporine [9, 101. We have
made some attempts employing polyclonal and monoclonal
antibodies to cyclosporine to determine whether the vacuoles in
our three cases contained the drug without success. The small
number of cases does not permit us to determine whether the
drug was truly absent from the vacuoles or whether the tech-
nique was inadequate to detect the material in the tubular cell.
There has been some debate concerning the means to assess
adequacy of the aspirated material. Kormendi regards the
presence of neutrophils as an important indicator of peripheral
blood contamination [11]. He suggests the employ of a set of
mathematical formulae to detect the abnormal presence of large
numbers of neutrophils within the aspirate which would reflect
contamination [ill. Belitsky et al [12] have recently reported
the use of an aspirate sampling index (ASI) in which the actual
concentration of renal tubular cells per high power microscopic
field of at least 0.25 permitted a biopsy to be rendered adequate
for diagnosis of the clinical events transpiring in animal models
carefully monitored. In our view, the original Helsinki ade-
quacy criteria permitted a diagnosis to be made in a substantial
fraction of aspirates tendered to the pathology laboratory with
high degree of accuracy confirming the clinical impression. The
Helsinki criteria appeared to us to be completely acceptable for
routine use of this technique in clinical practice.
The present understanding of the nature of the alloimmune
response states that it is Class 2 HLA transplantation antigenic
differences which initiate the afferent loop of the rejection
process. The role of passenger leukocytes in this initiation
process has been felt to be primal based on theoretical consid-
erations and experimental evidence [13]. In theory, the absence
of Class 2 HLA antigens on parenchymal cells requires that an
additional cell type or types be present to start the afferent
alloantigenic recognition process. This additional cell type may
be the passenger leukocyte sojourning in the transplant in its
passage from donor to recipient [13]. It is now clear that
activated helper lymphocytes may stimulate parenchymal cells,
including those of the kidney, to synthesize a complement of
surface Class 2 lILA antigens by releasing lymphokines such as
gamma interferon, expanding greatly the mass of alloantigen
capable of sensitization thereby amplifying the alloimmune
response [14, 15]. A similar process is felt operative for the
kidney allograft. Our findings with respect to DR staining of
tubular cells support this hypothesis. Additionally, our data
provide an important rationale for the early use of immunosup-
pressive drugs capable of inhibiting or delimiting lymphokine
production, such as cyclosporine, to reduce the episodes of
rejection experienced when the immunosuppressive regimen
did not include drugs with this capacity. The impact of anti-
rejection medications on the predictive nature of DR staining
from aspirate material must await serial studies which are being
conducted by our research team.
Our studies permit recommendations as to the instances in
which the fine needle aspiration biopsy technique will be most
useful clinically. Certainly, routine aspirations over time can be
taken as additional or adjunctive information to support the
clinical diagnosis established. The patient with a rapidly falling
serum creatinine or stable transplant function with creatinines
below 2.0 mg/dl do not require aspirations routinely unless
under the umbrella of a research protocol or to attempt to
discern an early immune event as yet clinically inapparent.
Most useful is the aspirate in the face of acute renal failure when
a rejection may be completely hidden by the lack of additional
bedside or laboratory evidence of immune activation. At least
one such instance appeared to have occurred in our prospective
study reported here. An additional such episode occurred in our
retrospective pilot study which was confirmed by core biopsy.
Because the presence of acute cellular rejection was the easiest
diagnosis to confirm, the absence of rejection by fine needle
aspirate in the face of failing renal function in a patient treated
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with cyclosporine may be taken, in the absence of surgical or
mechanical problems, as supportive of the diagnosis of cyclo-
sporine toxicity regardless of the presence of cytoplasmic
vacuolization.
Our studies confirm the utility of the fine needle aspiration
biopsy in routine practice of transplantation. It is important to
emphasize that our study design utilizing coded specimens
without further patient identification did not permit analysis of
the serial changes that characterize temporal changes in infil-
trating cells in response to appropriate therapy. Previous stud-
ies by the Finland group have made some comments about the
temporal sequence of events in the rejecting allograft gleaned
from study of unmodified animal models and from man treated
with a wide variety of immunosuppressive agents 3—5]. Con-
firmation by our group of the findings of Hayry and von
Willebrand with respect to these temporal issues must await
embarkation into serial studies using the fine needle technique
now validated in our hands.
In summary, our prospective, randomized, coded study of
the utility of fine needle aspiration biopsy has revealed that this
technique is a safe, convenient, easy means to assess the
immunologic and functional integrity of the renal allograft on a
frequent basis without complication. The aspirate may be
obtained more than once a day, without a great deal of patient
preparation, and even in the out-patient clinic facility. It is
suggested that the fine needle aspiration biopsy technique may
become a standard part of the diagnostic regimen in a clinical
transplant program.
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